ASH 2022 Conference Coverage
Playback speed
10 seconds
ASH 2022 Phase III ASAP Trial Results: Sequential Conditioning & Immediate alloHCT Results in Similar OS and LFS Compared to Intensive Remission Induction Chemo Followed By alloHCT In R/R AML
By
ASH 2022 Conference Coverage
FEATURING
Johannes Schetelig
By
ASH 2022 Conference Coverage
FEATURING
Johannes Schetelig
59 views
January 3, 2023
Login to view comments.
Click here to Login
Leukemia